DVAX — Dynavax Technologies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Annual balance sheet for Dynavax Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	165	546	624	742	714
Net Total Accounts Receivable
Net Total Receivables	22.7	132	148	44.5	46.9
Total Inventory
Prepaid Expenses
Total Current Assets	290	973	917	859	849
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	57.1	61	63.3	61.6	60.6
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	353	1,039	986	997	986
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	77.4	556	150	62.2	78.6
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	295	817	405	375	389
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	58.7	222	581	622	597
Total Liabilities & Shareholders' Equity	353	1,039	986	997	986
Total Common Shares Outstanding
Total Preferred Shares Outstanding